History of mental disorders and leukocyte telomere length in late adulthood: The Helsinki Birth Cohort Study (HBCS)

Journal of Psychiatric Research

Volumn 46, Issue 10, 2012, Pages 1346-1353

  Savolainen, Katri ^a   Räikkönen, Katri ^a   Kananen, Laura ^a,b   Kajantie, Eero ^c,d   Hovatta, Iiris ^a,b,c   Lahti, Marius ^a   Lahti, Jari ^a   Pesonen, Anu Katriina ^a   Heinonen, Kati ^a   Eriksson, Johan G ^a,c,e,f,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e FOLKHÄLSAN RESEARCH CENTER   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Antidepressant medication; Leukocyte telomere length; Mental disorder; Psychotropic medication; Substance use disorder

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ADULTHOOD; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; LEUKOCYTE; LEUKOCYTE TELOMERE LENGTH; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; PRESCRIPTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; TELOMERE; TREATMENT DURATION;

EID: 84865540568     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.07.005     Document Type: Article

References (63)

1. Aalto A., Aro A.R., Teperi J. RAND-36 as a measure of health related quality of life. Reliability, construct validity and reference values in the Finnish general population 1999, STAKES, Helsinki.
2. Arroyo C., Hu F.B., Ryan L.M., Kawachi I., Colditz G.A., Speizer F.E., et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004, 27:129-133.
3. Atzmon G., Cho M., Cawthon R.M., Budagov T., Katz M., Yang X., et al. Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:1710-1717.
4. Aviv A. Leukocyte telomere length: the telomere tale continues. The American Journal of Clinical Nutrition 2009, 89:1721-1722.
5. Aviv A., Chen W., Gardner J.P., Kimura M., Brimacombe M., Cao X., et al. Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa Heart Study. American Journal of Epidemiology 2009, 169:323-329.
6. Bakaysa S.L., Mucci L.A., Slagboom P.E., Boomsma D.I., McClearn G.E., Johansson B., et al. Telomere length predicts survival independent of genetic influences. Ageing Cell 2007, 6:769-774.
7. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clinical Psychology Review 1988, 8:77-100.
8. Berwick D.M., Murphy J.M., Goldman P.A., Ware J.E., Barsky A.J., Weinstein M.C. Performance of five-item mental health screening test. Medical Care 1991, 29:169-176.
9. Bischoff C., Petersen H.C., Graakjaer J., Andersen-Ranberg K., Vaupel J.W., Bohr V., et al. No association between telomere length and survival among the elderly and oldest old. Epidemiology 2006, 17:190-194.
10. Blackburn E.H. Telomere states and cell fates. Nature 2000, 408:53-56.
11. Blackburn E.H. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. Federation of European Biochemical Society 2004, 579:859-862.
12. Britt-Compton B., Capper R., Rowson J., Baird D.M. Short telomeres are preferentially elongated by telomerase in human cells. FEBS Letters 2009, 583:3076-3080.
13. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Research 2002, 30:e47.
14. Chan S.R., Blackburn E.H. Telomeres and telomerase. Philosophical Transactions of the Royal Society B: Biological Sciences 2004, 359:109-121.
15. Codd V., Mangino M., van der Harst P., Braund P.S., Kaiser M., Beveridge A.J., et al. Common variants near TERC are associated with mean telomere length. Nature Genetics 2010, 42:197-199.
16. Colton C.W., Manderscheid R.W. Preventing congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Chronic Diseases 2006, 3:42-55.
17. Damjanovic A.K., Yang Y., Glaser R., Kiecolt-Glaser J.K., Nquyen H., Laskowski B., et al. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. The Journal of Immunology 2007, 179:4249-4254.
18. Demissie S., Levy D., Benjamin E.J., Cupples L.A., Gardner J.P., Herbert A., et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell 2006, 5:325-330.
19. Eerola J., Kananen L., Manninen K., Hellstrom O., Tienari P.J., Hovatta I. No evidence for shorter leukocyte telomere length in Parkinson's disease patients. Journals of Gerontology Series A: Biological Sciences & Medical Sciences 2010, 65A:1181-1184.
20. Eriksson J.G., Forsén T., Tuomilehto J., Osmond C., Barker D.J.P. Early growth and coronary heart disease in later life: longitudinal study. British Medical Journal 2001, 322:949-953.
21. Farzaneh-Far R., Lin J., Epel E., Lapham K., Blackburn E., Whooley M.A. Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS One 2010, 5:e8612.
22. Fernandez-Egea E., Bernarno M., Heaphy C.M., Griffin J.K., Parellada E., Esmaties E., et al. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophrenia Bulletin 2009, 35:437-442.
23. Fitzpatrick A.L., Kronmal R.A., Gardner J.P., Psaty B.M., Jenny N.S., Tracy R.P., et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. American Journal of Epidemiology 2007, 165:14-21.
24. Frenck R.W., Blackburn E.H., Shannon K.M. The rate of telomere sequence loss in human leukocytes varies with age. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5607-5610.
25. Harris E.C., Barraclough B. Excess mortality of mental disorder. British Journal of Psychiatry 1998, 173:11-53.
26. Hartmann N., Boehner M., Groenen F., Kalb R. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depression and Anxiety 2010, 27:1111-1116.
27. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. American Heart Journal 2005, 150:1115-1121.
28. Hoen P., de Jonge P., Na B., Farzaneh-Far R., Epel E., Lin J., et al. Depression and leukocyte telomere length in patients with coronary heart disease: data from the heart and soul study. Psychosomatic Medicine 2011, 73:541-547.
29. Houben J.M., Giltay E.J., Rius-Ottenheim N., Hageman G.J., Kromhout D. Telomere length and mortality in elderly men: the Zutphen elderly study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2011, 66:38-44.
30. Huzen J., van der Harst P., de Boer R.A., Lesman-Leegte I., Voors A.A., van Gilst W.H., et al. Telomere length and psychological well-being in patients with chronic heart failure. Age and Ageing 2010, 39:223-227.
31. Kananen L., Surakka I., Pirkola S., Suvisaari J., Lönnqvist J., Peltonen L., et al. Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PloS One 2010, 5:e10826.
32. Kao H., Cawthon R.M., DeLisi L.E., Bertisch H.C., Ji F., Gordon D., et al. Rapid telomere erosion in schizophrenia. Molecular Psychiatry 2008, 13:118-119.
33. Kawanishi S., Oikawa S. Mechanism of telomere shortening by oxidative stress. Annals of the New York Academy of Sciences 2004, 1019:278-284.
34. Kimura M., Hjelmborg J.V., Garndner J.P., Bathum L., Brimacombe M., Lu X., et al. Telomere length and mortality: a study of leukocytes in elderly Danish twins. American Journal of Epidemiology 2008, 167:799.
35. Krishnan K. Psychiatric and medical comorbidities of bipolar disorder. Psychosomatic Medicine 2005, 67:1-8.
36. Lung F.W., Chen N.C., Shu B.C. Genetic pathway of major depressive disorder in shortening telomeric length. Psychiatric Genetics 2007, 17:195-199.
37. Mansour H., Chowdari K., Fathi W., Elassy M., Ibrahim I., Wood J., et al. Does telomere length mediate associations between inbreeding and increased risk for bipolar I disorder and schizophrenia?. Psychiatry Research 2011, 188:129-132.
38. Martin-Ruiz C.M., Gussekloo J., Van Heemst D., Von Zglincki T., Westendorp R.G. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population based study. Aging Cell 2005, 4:287-290.
39. Miller B.J., Paschall C.B., Svendsen D.P. Mortality and medical comorbidity among patients with serious mental illness. Psychiatric Services 2006, 57:1482-1487.
40. Mitchell A.J., Lawrence D. Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis. The British Journal of Psychiatry 2011, 198:434-441.
41. Najt P., Fusar-Poli P., Brambilla P. Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychiatry Research 2011, 186:159-164.
42. Njajou O.T., Wen-Chi H., Blackburn E.H., Newman A.B., Shih-Hsuan W., Li R., et al. Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. Journals of Gerontology Series A: Biological Sciences & Medical Sciences 2009, 64A:860-864.
43. Nordfjäll K., Svenson U., Norrback K.-F., Adolfsson R., Lenner P., Göran R. The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genetics 2009, 5:e1000375.
44. O'Callaghan N., Dhillon V., Thomas P., Fenech M. A quantitative real-time PCR method for absolute telomere length. Biotechniques 2008, 44:807-809.
45. Osmond C., Kajantie E., Forsén T.J., Eriksson J.G., Barker D.J.P. Infant growth and stroke in adult life. Stroke 2007, 38:264-270.
46. Pavanello S., Hoxha M., Dioni L., Bertazzi P.A., Snenghi R., Nalesso A., et al. Shortened telomeres in individuals with abuse in alcohol consumption. International Journal of Cancer 2011, 129:983-992.
47. Räikkönen K., Lahti M., Heinonen K., Pesonen A., Wahlbeck K., Kajantie E., et al. Risk of severe mental disorders in adults separated temporarily from their parents in childhood: The Helsinki Birth Cohort Study. Journal of Psychiatric Research 2011, 45:332-338.
48. Report of a WHO Consultation Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus 1999, World Health Organization, Geneva.
49. Rugulies R. Depression as a predictor for coronary heart disease. American Journal of Preventive Medicine 2002, 23:51-61.
50. Salpea K.D., Talmud P.J., Cooper J.A., Maubaret C.G., Stephens J.W., Abelak K., et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010, 209:42-50.
51. Simon N.M., Smoller J.W., McNamara K.L., Maser R.S., Zalta A.K., Pollack M.H., et al. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biological Psychiatry 2006, 60:432-435.
52. Spencer R.L., Hutchison K.E. Alcohol, aging, and the stress response. Alcohol Research & Health 1999, 23:272-281.
53. Valdes A.M., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366:662-664.
54. Vogelzangs N., Seldenrijk A., Beekman A.T.F., van Hout H.P.J., de Jonge P., Penninx B.W.J.H. Cardiovascular disease in persons with depressive and anxiety disorders. Journal of Affective Disorders 2010, 125:241-248.
55. von Zglinicki T. Oxidative stress shortens telomeres. Trends of Biochemical Science 2002, 27:339-344.
56. von Zglinicki T., Serra V., Lorenz M., Saretzki G., Lenzen-Grossimlighaus R., Risch A., et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor?. Lab Investigation 2000, 80:1739-1747.
57. Wahlbeck K., Westman J., Nordentoft M., Gissler M., Laursen T.M. Outcomes of nordic mental health systems: life expectancy of patients with mental disorders. The British Journal of Psychiatry 2011, 199:453-458.
58. Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 health survey: Manual interpretation and guide 1993, Nimrod Press, Boston.
59. Wolkowitz O.M., Mellon S.H., Epel E.S., Lin J., Dhabhar E.F., Su Y., et al. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress-preliminary findings. PLoS ONE 2011, 6:e17837.
60. Wong J.M., Collins K. Telomere maintenance and disease. Lancet 2003, 362:983-988.
61. Yang Z., Huang X., Jiang H., Zhang Y., Liu H., Qin C., et al. Short telomeres and prognosis of hypertension in a Chinese population. Hypertension 2009, 53:639-645.
62. Yu W.Y., Chang H.W., Lin C.H., Cho C.L. Short telomeres in patients with chronic schizophrenia who show a poor response to treatment. Journal of Psychiatry & Neuroscience 2008, 33:244-247.
63. Zafir A., Ara A., Banu N. In vivo antioxidant status: a putative target of antidepressant action. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:220-228.